Image
Health Team

Duke Study Gives Boost to White Blood Cell Drugs

A drop in a cancer patient's white blood cell count can sometimes lead a physician to stop or reduce chemotherapy. So, Duke University researchers are examining the risks and benefits of white blood cell boosters.